The Influences of Single Chamber vs. Multi-chamber Blood Flow Restriction Cuffs
The Influences of Single Chamber vs. Multi-chamber Blood Flow Restriction Cuffs on Post-exercise Arterial Stiffness, Perceptual Responses and Performance
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Salisbury, Maryland, United States, 21801
- Salisbury University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Physically active (> 1,000 MET/min/wk) for at least six months.
- Weight stable for previous 6 months (+/-2.5 kg)
- Female subjects only- reported regular menstrual cycles for the last 2 years
Exclusion Criteria:
- BP>140/90 mmHg
- BMI>40 kg/m2
- Diabetes
- Familial hypercholesterolemia
- Past or current history of CHD, stroke or major CVD events. Respiratory diseases (not including asthma), endocrine or metabolic, neurological, or hematological disorders that would compromise the study or the health of the subject.
- Women must not be pregnant, plan to become pregnant during the study, or be nursing
- Active renal or liver disease
- All medications and supplements that influence dependent variables*
- Recent surgery < 2 months
- Alcohol abuse
- Sleep apnea
- Claustrophobia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: single chamber blood flow restriction cuff
Single Chamber BFR (Delfi, Vancouver, Canada) training devices will be used for exercise and testing sessions (see attachment).
Cuffs will be placed around the right and left proximal thigh.
The LOP will be set at 60% immediately before exercise and will be applied during the entire exercise set (approximately 30-60 seconds in duration) in accordance with manufacturer specifications.
The cuffs will maintain pressure during training and rest periods.
The LOP will be decreased to 0% immediately after the set is completed.
|
Cuffs will be worn throughout the entire training session.
Training session consist of lower intensity wall squats.
Four sets of wall squats will be performed to failure.
Arterial stiffness and muscle morphological assessments will be conducted before and after the exercise.
Other Names:
|
|
Experimental: Multiple chamber blood flow restriction cuff
Multiple chamber BFR (B-Strong, Park City, UT) training devices will be used for exercise and testing sessions (see attachment).
Cuffs will be placed around the right and left proximal thigh.
The LOP will be set at 60% immediately before exercise and will be applied during the entire exercise set (approximately 30-60 seconds in duration) in accordance with manufacturer specifications.
The cuffs will maintain pressure during training and rest periods.
The LOP will be decreased to 0% immediately after the set is completed.
|
Cuffs will be worn throughout the entire training session.
Training session consist of lower intensity wall squats.
Four sets of wall squats will be performed to failure.
Arterial stiffness and muscle morphological assessments will be conducted before and after the exercise.
Other Names:
|
|
Placebo Comparator: No BFR cuff
No cuff will be worn during the training session.
|
Cuffs will be worn throughout the entire training session.
Training session consist of lower intensity wall squats.
Four sets of wall squats will be performed to failure.
Arterial stiffness and muscle morphological assessments will be conducted before and after the exercise.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial Stiffness
Time Frame: Prior to and 10-minutes after the exercise intervention
|
A measurement of vascular health.
|
Prior to and 10-minutes after the exercise intervention
|
|
Muscle Morphology
Time Frame: Prior to and immediately after the exercise intervention
|
A measurement of vastus lateralis cross sectional area
|
Prior to and immediately after the exercise intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 301 (Yasar Calıskan)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.